Lonial Sagar
- SEC CIK
- 0001816609
No open-market purchases or sales filed in the past year.
Current role at each company
- TGTX TG Therapeutics, Inc.Directoras of Jun 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lonial Sagar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 (view filing) | Sep 11 | 1 day | Lonial SagarDirector | SSale | −20.9K | $32.24 | −$672.3K | −18.1%94.1K after | |
| Nov 12, 2024 (view filing) | Nov 11 | 1 day | Lonial SagarDirector | SSale | −5.00K | $30.44 | −$152.2K | −4.8%100.2K after | |
| Jun 20, 2024 (view filing) | Jun 17-20 | 3 days | Lonial SagarDirector | SSale | −25.9K | $16.69 | −$432.9K | −19.8%105.2K after | 2 lots |
| Mar 15, 2024 (view filing) | Mar 13 | 2 days | Lonial SagarDirector | SSale | −5.00K | $15.94 | −$79.7K | −4.4%108.9K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Lonial SagarDirector | SSale | −34.9K | $23.37 | −$814.5K | −27.1%93.9K after |